James D. Berry - Concepedia

Author

James D. Berry

Also Known As

Berry, James, Berry, James D., Christina N. Fournier, David Benatar, J Berry, J D Berry, J. Berry, J. D. BERRY, J. D. Berry, J. R. Berry

416

Publications

12.7K

Citations

H-Index

133

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Clinical Research Institute Spaulding Rehabilitation Hospital MGH Institute of Health Professions

About

James D. Berry is an author at Massachusetts General Hospital specializing in medicine, neurology, and neurodegenerative diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	28	1.6K
2	Health Sciences	9	9	478
3	Education	1	1	20
4	Natural Sciences	1	1	52
5	Nursing	1	1	15

James D. Berry

112

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons Brian J. Wainger, Evangelos Kiskinis, Cassidy Mellin, Cell Reports	2014	661
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix, New England Journal of Medicine	2020	505
TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A Anna‐Leigh Brown, Oscar G. Wilkins, Matthew J. Keuss, Nature	2022	471
Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS Zhaoming Su, Yong‐Jie Zhang, Tania F. Gendron, Neuron Amyotrophic Lateral SclerosisMolecular BiologyLead Small MoleculesMolecular DiagnosticsCell Biology	2014	353
Targeting mi<scp>R</scp>‐155 restores abnormal microglia and attenuates disease in <scp>SOD</scp>1 mice Oleg Butovsky, Mark P. Jedrychowski, Ron Cialic, Annals of Neurology	2014	346
The PRO-ACT database Nazem Atassi, James D. Berry, Amy M. Shui, Neurology	2014	278
Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i> -associated amyotrophic lateral sclerosis Tania F. Gendron, Jeannie Chew, Jeannette N. Stankowski, Science Translational Medicine	2017	266
Bulbar and speech motor assessment in ALS: Challenges and future directions Jordan R. Green, Yana Yunusova, Mili Kuruvilla-Dugdale, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Bulbar Motor DeclineAmyotrophic Lateral SclerosisBulbar Motor DeteriorationHealth SciencesSpeech Kinematics	2013	219
Long‐term survival of participants in the <scp>CENTAUR</scp> trial of sodium phenylbutyrate‐taurursodiol in <scp>amyotrophic lateral sclerosis</scp> Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson, Muscle & Nerve	2020	174
Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines Emily G. Baxi, Terri G. Thompson, Jonathan Li, Nature Neuroscience	2022	148

Page 1